Screening for, and characterisation of, novel immune cell extravasation genes in Drosophila, mice and man

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

March 03, 2027
Response Due
Active
Status

Opportunity Overview

An inflammatory response is pivotal in many normal physiological responses, for example wherever there is a wound or site of infection. In such scenarios, if inflammation is delayed or insufficient then the consequences to health can be catastrophic. Conversely, if the inflammatory response is excessive or slow to resolve, then 'chronic' inflammation can also lead to several pathologies, ranging from tissue scarring through to atherosclerosis or even cancer. A better understanding of how inflammatory cells are recruited to their target tissues will help guide us how the inflammatory response might be modulated therapeutically to treat these conditions.

One of the key 'rate-limiting' steps in an inflammatory response is the movement of leukocytes (white blood cells) from the circulation across blood vessel walls (known as 'extravasation') to sites of damage or infection. However, despite decades of research in this field, many aspects of this step in leukocyte recruitment remain poorly understood and there is still much to learn; this is in part because breaching of vessel walls is a highly complex process to dissect at the molecular level and it is incredibly difficult to image in opaque tissues of traditional mammalian models (e.g. mouse).

In Bristol we have recently developed a new model in which to study immune cell 'extravasation' using the fruitfly, Drosophila. Fruitflies offer many advantages for this research, being genetically 'tractable' (easy to mutate and study individual genes) and also translucent (enabling us to watch these movements live using microscopy). Since fruitflies largely have an 'open circulation' without discrete blood vessels, they were not previously considered a useful model for this field. However, we have identified a period in pupal life when immune cells circulate through the wing "veins" and a laser-induced wound triggers immune cells to leave the veins and move towards the damage. We have already used this model to...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedOctober 03, 2021
Procurement stageActive solicitation
Response dueMarch 03, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.